Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications from the Centre for Immuno-Oncology

Unlocking cancer vaccine potential: What are the key factors?

Journal article

Grant M. et al, (2024), Human vaccines & immunotherapeutics, 20

Vaccination against the Epstein-Barr virus.

Journal article

Rühl J. et al, (2020), Cellular and molecular life sciences : CMLS, 77, 4315 - 4324

Heterologous prime-boost vaccination protects against EBV antigen-expressing lymphomas.

Journal article

Rühl J. et al, (2019), The Journal of clinical investigation, 129, 2071 - 2087

Immunotherapy and Vaccine Development.

Journal article

Leung C. et al, (2018), Journal of immunology research, 2018

Animal models of Epstein Barr virus infection.

Journal article

Chatterjee B. et al, (2014), Journal of immunological methods, 410, 80 - 87

Infectious diseases in humanized mice.

Journal article

Leung C. et al, (2013), European journal of immunology, 43, 2246 - 2254

Load More